Form 4 for BCYC BICYCLE THERAPEUTICS PLC
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0002015378-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-06 | 2026-01-02+ | BCYC | Hannay Michael Charles Ferguson | CHIEF PROD, SUPPLY CHAIN OFF | S - Sale | $6.64 | -5,194 | 100.3K | -5% | -$34.5K |
| D | 2026-01-06 | 2026-01-02 | BCYC | Hannay Michael Charles Ferguson | CHIEF PROD, SUPPLY CHAIN OFF | A - Grant | $0.00 | +50.0K | 103.1K | +94% | $0 |
| D | 2026-01-06 | 2026-01-02 | BCYC | Hannay Michael Charles Ferguson | CHIEF PROD, SUPPLY CHAIN OFF | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-01-05 | S | D | 2,367 | $6.45 | 97,908 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.30 to $6.70 inclusive. |
| 2 | Common | Ordinary Shares | 2026-01-02 | A | A | 50,000 | $0.00 | 103,102 | D | — | — | (F1) Represents a restricted share unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 2, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter. (F2) Each RSU represents a contingent right to receive one ordinary share. |
| 3 | Common | Ordinary Shares | 2026-01-02 | S | D | 2,827 | $6.80 | 100,275 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.62 to $7.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) and (5). |
| 4 | Derivative | Employee Stock Option (right to buy) | 2026-01-02 | A | A | 100,000 | $0.00 | 100,000 | D | $7.08 · — to 2036-01-02 | 100,000 Ordinary Shares | (F6) This option shall vest with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares in 36 equal monthly installments thereafter. |